Ovarian cancer is one of the deadliest gynaecological cancers, yet there currently is no early diagnostic test. Here’s what you need to know.

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Amy Van Wyk had a seizure while on holiday in South Africa and was given the devastating news her ovarian cancer had ...

ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines. To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery ...

PETALING JAYA: Health screenings which are both affordable and convenient encourage women to get regular check-ups. Senior ...

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

Three of the nine inspirational women, Debbie, Elaine and Dawn, who have taken part in a ground-breaking in podcast, Sex And ...

A Pap smear or Pap test is a screening test for cervical cancer. There’s currently no easy and reliable early screening test for ovarian cancer. A Pap smear or Pap test doesn’t help doctors ...

Previous abdominal organ datasets were compiled by radiologists manually identifying and labeling individual organs in CT scans, requiring thousands of hours of human labor. "Annotating 45,000 CT ...

"This process is like a cosmic CT scan, where we can look through different slices of cosmic history and track how matter clumped together at different epochs." A powerful combination of data from ...

The TAB-EOAO study: Trends in use and benefit of adjuvant chemotherapy between early onset and average onset locally advanced colon cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Imaging studies, including transvaginal ultrasound and CT scans, provide detailed views of the reproductive organs. Blood tests measuring CA-125 levels can indicate potential ovarian cancer ...